Gen-Probe's Michael Watts sees five potential new product launches as delivering top-line growth next year.
Cara Esser explains the fundamentals behind Morningstar's CEF Analyst Ratings and what investors should keep in mind before buying or selling a fund.
Aptar COO Steve Hagge on how the firm's close client relationships and FDA-approved dispensers give the firm an advantage in consumer packaging.
Headlines this week revealed a new nomination but an old hat at the Treasury, a new direction for an old-line grocer, and same-old, same-old at the ECB--for now, anyway.
©2012 Morningstar Advisor. All right reserved.